Mannatech Patents for Ambrotose® Validated in Case Against Techmedica and Ionx

by louabbott on January 15, 2010

Mannatech published this press release  on January 13, 2010 regarding the patent infringement lawsuit initially file in May of 2006:

As usual, the wheels of justice turn slowly…

Mannatech, Incorporated (NASDAQ: MTEX), a global pioneer in the development of high-quality health, weight and fitness and skin care solutions based on nutritional science, obtained a Final Judgment and Permanent Injunction in its lawsuit against Techmedica Health (Techmedica), and Ionx Holdings (Ionx) prohibiting them from the manufacture, use or sale of products infringing Mannatech’s patents and requiring them to pay Mannatech $250,000 in damages.

In May 2006, Mannatech filed a lawsuit against Techmedica and Ionx in the United States District Court for the Northern District of Texas, Dallas Division alleging infringement of Mannatech’s patents (U.S. Patents 6,929,807; 7,157,431; 7,196,064; 7,199,104; and 7,202,220).1 The parties recently agreed to settle this case and, pursuant to their agreement, United States District Judge Solis entered his Final Judgment and Permanent Injunction.

“This judgment further validates that our patents are good, valid and enforceable under law, and that Mannatech will vigorously enforce its rights under these patents,” said Keith Clark, Mannatech executive vice president and chief legal officer. Mannatech was represented by Eric Pinker, Mark Turk and Renee Strickland, with the Dallas-based litigation firm of Lynn Tillotson Pinker & Cox, LLP.

The final judgment includes findings that Mannatech’s patents are “valid and enforceable” and infringed by Techmedica and Ionx. Additionally, it includes a broad injunction that prohibits Techmedica and Ionx from “making, using, offering to sell, selling, or otherwise distributing within the United States, or importing into the United States, infringing products, which include the current formulations of Activive ®, Candidol ®, Claritose ®, Lupazol ®, Nutratose ®, Respitrol ®, Rhumatol ®, Synaptol ® and Viratrol ®, as well as any other products that infringe the patents in suit” and further awards Mannatech damages of $250,000.

The settlement with Ionx and Techmedica comes on the heels of several rulings in the lawsuit favorably construing Mannatech’s patents, and is the latest in a series of cases in which Mannatech has obtained injunctions preventing companies from infringing on Mannatech’s patents.

1 Case 3:06-cv-0813, U.S. District Court, Northern District of Texas, Dallas Division, Filed May 5, 2006.

The full press release can be read here.

Be Sociable, Share!

{ 2 comments… read them below or add one }

John Chatman January 20, 2010 at 1:56 am Thumb up 0 Thumb down 0

Good news for Mannatech! I have several friends who are building in that company and are having a fantastic time doing it.

To Our Massive Success,
John

Reply

Don December 1, 2011 at 2:31 pm Thumb up 0 Thumb down 0

I have ha so many problem with my joint after using these Products. I’m looking for an attorney that will take this case

Reply

Leave a Comment

Thoughtful and constructive comments that benefit network marketing professionals and the industry will be accepted and published after review.
We will not publish rude or insulting comments, plugs for your company or product, or generally non-helpful or self-promoting content.


Previous post:

Next post: